![AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-020-03030-7/MediaObjects/41419_2020_3030_Fig1_HTML.png)
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease
![Hepatocellular Carcinoma: Illustrated Guide to Systematic Radiologic Diagnosis and Staging According to Guidelines of the American Association for the Study of Liver Diseases | RadioGraphics Hepatocellular Carcinoma: Illustrated Guide to Systematic Radiologic Diagnosis and Staging According to Guidelines of the American Association for the Study of Liver Diseases | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.336125104/asset/images/medium/125104t01.gif)
Hepatocellular Carcinoma: Illustrated Guide to Systematic Radiologic Diagnosis and Staging According to Guidelines of the American Association for the Study of Liver Diseases | RadioGraphics
Osteopontin as a Tumor Marker for Hepatocellular Carcinoma | Mohamed | Journal of Gastroenterology and Hepatology Research
![A focused review on recent advances in diagnosis and management of fibrolamellar hepatocellular carcinoma A focused review on recent advances in diagnosis and management of fibrolamellar hepatocellular carcinoma](https://i.oaes.cc/images_2018/journals/forabstract/hr/4863.png)
A focused review on recent advances in diagnosis and management of fibrolamellar hepatocellular carcinoma
![Table 1 from Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer | Semantic Scholar Table 1 from Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0e7999631a1088cb9c80cdfe055ccbc9f6a143f6/6-Table1-1.png)
Table 1 from Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer | Semantic Scholar
![Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells - ScienceDirect Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001618301916-fx1.jpg)
Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells - ScienceDirect
![Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know](https://pub.mdpi-res.com/cancers/cancers-14-01493/article_deploy/html/images/cancers-14-01493-g001.png?1647332793)
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
![Cellular prognostic markers in hepatitis-related hepatocellular carcinoma | Infectious Agents and Cancer | Full Text Cellular prognostic markers in hepatitis-related hepatocellular carcinoma | Infectious Agents and Cancer | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13027-018-0183-8/MediaObjects/13027_2018_183_Fig1_HTML.gif)
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma | Infectious Agents and Cancer | Full Text
![IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma](https://www.mdpi.com/ijms/ijms-22-10271/article_deploy/html/images/ijms-22-10271-g001.png)